After determining PRDX5 as the most significant prognostic factor in the PRDX family, we developed a nomogram integrating PRDX5 expression with clinical features to better predict clinical outcomes in prostate cancer patients than 30 other 30 public gene signatures. Here, PRDX5 is linked to prostate cancer.